CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 8-K Event Results of operations
- 4 Open-market sale 10% owner sold 38,304 shares at $8.99 ($344,418)
- 4 Open-market sale 10% owner sold 6,848 shares at $8.95 ($61,290)
- 4 Open-market sale 10% owner sold 97,000 shares at an average $10.29 ($997,778)
- 4 Open-market buy Director bought 10,000 shares at an average $10.39 ($103,938)
- 4/A Open-market buy Director bought 5,000 shares at $10.05 ($50,250)
- 4 Open-market sale 10% owner sold 36,000 shares at an average $10.47 ($376,890)
- 4 Open-market buy Director bought 4,967 shares at $10.05 ($49,918)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market buy Director bought 20,000 shares at $9.24 ($184,844)
- 4 Open-market buy Director bought 10,000 shares at $9.10 ($91,048)
- 4 Grant or award Chief Financial Officer acquired 36,443 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Open-market sale 10% owner sold 26,000 shares at $13.28 ($345,361)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale See Remarks sold 55,321 shares at $13.64 ($754,307)
Page 13 of 28 · 558 filings